Recombinant IL13 (Lebrikizumab Biosimilar) 抗体
This anti-IL13 (Lebrikizumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting IL13 (Lebrikizumab Biosimilar) in ELISA. Suitable for 人.
产品编号 ABIN7487944
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant IL13 (Lebrikizumab Biosimilar) 抗体 (ABIN7487944)
抗原
IL13 (Lebrikizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This IL13 (Lebrikizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Lebrikizumab Biosimilar - Anti-IL13 mAb
-
产品特性
- Antibody Type: IgG4-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- IL13 (Lebrikizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
MILR1444A,PRO301444
Lebrikizumab is a humanized monoclonal antibody targeting IL13, it is an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. -
CAS-编号
- 953400-68-5
抗原
-
You are here:
